A Study to Assess the Safety and Tolerability of Fezolinetant in Women Seeking Treatment for Relief of Vasomotor Symptoms (VMS) Associated With Menopause
Clinical trial NCT04451226 · COMPLETED
Trial details
- NCT number
- NCT04451226
- Sponsor
- Astellas Pharma China, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-30
- Primary completion
- 2022-06-13
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.